QDJ

Direct-To-Consumer Access Pharmacogenetic Assessment System

产品代码
QDJ
器械名称
Direct-To-Consumer Access Pharmacogenetic Assessment System
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 862.3364
FDA 专业组
Medical Genetics
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
3 件

FDA 分类定义

A direct-to-consumer access pharmacogenetic assessment system is a qualitative in vitro molecular diagnostic system used for detecting variants in nucleic acids isolated from human specimens the purpose of identifying pharmacogenetic associations for the detected variants. This device is for in vitro diagnostic use only, and is intended for direct access testing by lay users.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

FDA 官方分类页: QDJ
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。